148 results on '"Peng, Baogang"'
Search Results
2. A novel nomogram based on preoperative parameters to predict posthepatectomy liver failure in patients with hepatocellular carcinoma
3. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma
4. Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma
5. Microvascular Invasion Status and Its Survival Impact in Hepatocellular Carcinoma Depend on Tissue Sampling Protocol
6. YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice
7. Regional liver function analysis with gadoxetic acid–enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC
8. Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A
9. Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
10. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery
11. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy
12. The prognostic value of neuromedin U in patients with hepatocellular carcinoma
13. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1–5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study
14. Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by Apatinib
15. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment
16. A modified method for isolating mouse islets of an adequate quality, quantity, and purity
17. Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).
18. Two-wave mixing of ion-implanted photorefractive waveguides in near-stoichiometric Fe:LiNbO 3 crystals
19. Salvage resection for recurrent hepatocellular carcinoma after percutaneous ablation therapy: Old therapy served as new strategy: EFP6
20. Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
21. LncSNHG3/miR-139-5p/BMI1 axis regulates proliferation, migration, and invasion in hepatocellular carcinoma
22. Two-stages resection for advanced hepatocellular carcinoma
23. High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular Carcinoma.
24. Three‐day postoperative antibiotics reduces post‐hepatectomy infection rate in hepatitis B virus‐related hepatocellular carcinoma.
25. Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study.
26. GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma.
27. Deep Learning Radiomics Based on Contrast-Enhanced Ultrasound Might Optimize Curative Treatments for Very-Early or Early-Stage Hepatocellular Carcinoma Patients.
28. Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma.
29. Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma.
30. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
31. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation.
32. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.
33. Effects of intratumoral injection of immunoactivator after microwave ablation on antitumor immunity in a mouse model of hepatocellular carcinoma.
34. Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis.
35. Prediction of Microvascular Invasion in Hepatocellular Carcinoma: Preoperative Gd-EOB-DTPA-Dynamic Enhanced MRI and Histopathological Correlation.
36. CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study.
37. Salvage resection for recurrent or metastatic hepatocellular carcinoma after percutaneous ablation therapy.
38. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
39. Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy.
40. The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma.
41. Two-wave mixing of ion-implanted photorefractive waveguides in near-stoichiometric Fe:LiNbO3 crystals
42. Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model.
43. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway.
44. High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma.
45. Su1059 ALPPS for Hepatocellular Carcinoma With Cirrhosis.
46. Thrombocytopenia and the outcomes of hepatectomy for hepatocellular carcinoma: a meta-analysis.
47. High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma.
48. N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression.
49. Potential Common Molecular Mechanisms Between Periodontitis and Hepatocellular Carcinoma: A Bioinformatic Analysis and Validation.
50. Vitamin B6 Metabolic Pathway is Involved in the Pathogenesis of Liver Diseases via Multi-Omics Analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.